# Filing Detail

Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001178913-25-003532
Filing Date
2025-10-21
Accepted
2025-10-21 07:03:30
Documents
2

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B3 | zk2533856.htm | 424B3 | 10901
2 |  | image0.jpg | GRAPHIC | 539361
| Complete submission text file | 0001178913-25-003532.txt |  | 754716

Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 424B3 | Act: 33 | File No.: 333-288324 | Film No.: 251405347
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)